Table 2. Participant characteristics.
| All participants (n=101) | Group 1 (n=50) | Group 2 (n=51) | |
|---|---|---|---|
| Female, n (%) | 66 (65.3%) | 35 (70%) | 31 (60.8%) |
| Accuhaler users, n (%) | 54 (53.5%) | 26 (52%) | 28 (54.9%) |
|
Age
| |||
| 18–25 years | 24 (23.8%) | 11 (22.0%) | 13 (25.5%) |
| 26–40 years | 21 (20.8%) | 11 (22.0%) | 10 (19.6%) |
| 41–60 years | 25 (24.8%) | 10 (20.0%) | 15 (29.4%) |
| 61+years | 31 (30.7%) | 18 (36.0%) | 13 (25.5%) |
| Previous information received on how to use the inhaler, n (%) | 89 (88.0%) | 41 (82.0%) | 48 (94.0%) |
|
Source of previous inhaler information, n (%)
| |||
| General practitioner | 48 (54.5%) | 24 (58.5%) | 24 (50.0%) |
| Pharmacist | 15 (16.9%) | 6 (14.6%) | 9 (18.8%) |
| A doctor+a pharmacist | 23 (25.8%) | 10 (24.3%) | 13 (27.1%) |
| CMI | 2 (2.2%) | 1 (2.4%) | 1 (2.1%) |
| Pulmonary nurse | 1 (1.1%) | 0 (0%) | 1 (2.1%) |
|
Form of information previously received, n (%)
| |||
| PD+VI | 35 (39.3%) | 18 (43.9%) | 17 (35.4%) |
| VI only | 19 (21.3%) | 10 (24.4%) | 9 (18.75%) |
| WI only | 13 (14.6%) | 5 (12.2%) | 8 (16.7%) |
| WI+VI | 1 (1.1%) | 1 (2.4%) | 0 (0%) |
| WI+PD+VI | 21 (23.6%) | 7 (17.1%) | 14 (29.2%) |
|
Time length since last duration, n (%)
| |||
| <1 month | 2 (2.2%) | 2 (4.9%) | 0 (0%) |
| 1–5 months | 19 (21.3%) | 8 (19.5%) | 11 (22.9%) |
| 6–11 months | 7 (7.9%) | 2 (4.9%) | 5 (10.4%) |
| 1–2 years | 26 (29.2%) | 13 (31.7%) | 13 (27.1%) |
| >2 years | 35 (39.3%) | 16 (39.0%) | 19 (39.6%) |
| Asthma Control Questionnaire score at baseline (mean±s.d.) | 1.67±0.98 | 1.70±1.01 | 1.60±0.96 |
Abbreviations: CMI, consumer medicine information; IM, Inhalation Manager; PD, physical demonstration; VI, verbal information; WI, written information; WI, written information. n=49 in Group 1 (ACC, n=27; TH, n=22), n=48 in Group 2 (ACC, n=26; TH, n=22).